Long‐term outcomes of high‐dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall‐cell lung cancer

Long‐term outcomes of high‐dose (74 GyE) proton beam therapy with concurrent chemotherapy for stage III nonsmall‐cell lung cancer

Abstract Background To evaluate the long‐term outcomes of high‐dose (74 GyE) proton beam therapy (PBT) with concurrent chemotherapy for stage III non‐small cell lung cancer (NSCLC). Methods Between July 2007 and March 2018, 45 patients with stage III NSCLC were treated with passive‐scattering PBT of...

Full description

Bibliographic Details
Main Authors: Kayoko Ohnishi, Hitoshi Ishikawa, Kensuke Nakazawa, Toshihiro Shiozawa, Yutaro Mori, Masatoshi Nakamura, Toshiyuki Okumura, Ikuo Sekine, Nobuyuki Hizawa, Hideyuki Sakurai
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Thoracic Cancer
Subjects:
concurrent chemotherapy
proton beam therapy
stage III non‐small cell lung cancer
Online Access:https://doi.org/10.1111/1759-7714.13896

Internet

https://doi.org/10.1111/1759-7714.13896

Similar Items